Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: russet who wrote (757)	4/24/2002 1:55:34 AM
From: Canuck Dave	Read Replies (2) \| Respond to of 1590

"A man's gotta know his limitations" CD

To: russet who wrote (757)	5/9/2002 8:35:01 PM
From: Al Collard	Read Replies (1) \| Respond to of 1590

ONC-t...in the news: Oncolytics Announces Distribution of Oncolytics' Shares held by SYNSORB to SYNSORB Shareholders Oncolytics Announces Distribution of Oncolytics' Shares held by SYNSORB to SYNSORB Shareholders

To: russet who wrote (757)	6/14/2002 7:59:13 AM
From: Al Collard	Respond to of 1590

ONC-t...in the news: Oncolytics to acquire interest in Transition Therapeutics newswire.ca

To: russet who wrote (757)	7/3/2002 5:19:13 PM
From: Al Collard	Respond to of 1590

ONC-t...in the news: Oncolytics Commences Phase I/II Brain Cancer Trial newswire.ca

To: russet who wrote (757)	9/25/2002 10:26:50 AM
From: Al Collard	Respond to of 1590

ONC-t...in the news: Oncolytics Biotech Inc. Announces Issuance of Fifth U.S. Patent Covering REOLYSIN(R) Technology newswire.ca

To: russet who wrote (757)	10/10/2002 8:41:17 AM
From: Al Collard	Read Replies (1) \| Respond to of 1590

ONC-t...in the news: Oncolytics Biotech Announces Appointment of Senior Vice President, Clinical and Regulatory Affairs newswire.ca